Literature DB >> 18070520

[Analysis of the CYP1B1 gene mutation in primary congenital glaucoma patients of Hubei Han nationality].

Fa-gang Jiang1, Xiao-wen Liu, He-ping Hou.   

Abstract

OBJECTIVE: To identify novel CYP1B1 gene mutation in primary congenital glaucoma (PCG) patients of Hubei Han nationality and establish the possibility of gene diagnosis of PCG.
METHODS: Forty-seven patients with PCG and 100 normal subjects were studied. Genomic DNA was extracted from the peripheral leukocytes of all subjects. Mutation in exon2 and exon3 of CYP1B1 gene was detected in patients and control subjects by polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP), denaturing high performance liquid chromatograph (DHPLC), and direct sequencing DNA techniques.
RESULTS: Compared to normal subjects, a novel mutation was first time identified by direct sequencing demonstrating a homozygous C-to-T transition at codon 385 (CTT to TTT) which produced L385F mutation of CYP1B1 gene in 7 of the 47 patients with PCG.
CONCLUSIONS: The novel mutation in exon 3 of CYP1B1 found in PCG patients of Hubei Han nationality was probably pathological mutant gene by nature. It is important that further study be conducted to seek for the specific mutations of CYP1B1 gene and underlying pathological mechanism of PCG patients of Han nationality.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18070520

Source DB:  PubMed          Journal:  Zhonghua Yan Ke Za Zhi        ISSN: 0412-4081


  2 in total

1.  CYP1B1 gene mutations with incomplete penetrance in a Chinese pedigree with primary congenital glaucoma: a case report and review of literatures.

Authors:  Ling Chen; Lina Huang; Aineng Zeng; Jing He
Journal:  Int J Clin Exp Med       Date:  2015-08-15

Review 2.  Genetic, Biochemical and Clinical Insights into Primary Congenital Glaucoma.

Authors:  Muneeb Faiq; Reetika Sharma; Rima Dada; Kuldeep Mohanty; Daman Saluja; Tanuj Dada
Journal:  J Curr Glaucoma Pract       Date:  2013-05-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.